Home › Funds › Yorkville Advisors Global, LP › VRXA
Yorkville Advisors Global, LP position in VRXA
Veraxa Biotech AG
Yorkville Advisors Global, LP reported holding 1,041,581 shares of VRXA (Veraxa Biotech AG) in its Q3 2026 13F filing — a position valued at US$1.3M, representing 1.18% of its reported portfolio and ranking #15 among its reported holdings. Yorkville Advisors Global, LP first reported this position in Q3 2026.
Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR
How Yorkville Advisors Global, LP's VRXA position evolved
Yorkville Advisors Global, LP first disclosed a stake in VRXA in Q3 2026 at 1,041,581 shares (US$1.3M).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2026 | 1.04M | $1.30M | New |
About VRXA and 13F data
VRXA (Veraxa Biotech AG) is a company whose sector is not yet classified in our data. 6 other funds we track also report a position in VRXA. Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
More on Yorkville Advisors Global, LP
FAQ
How long has Yorkville Advisors Global, LP held VRXA?
Yorkville Advisors Global, LP has disclosed VRXA holdings in 1 of the last 1 reported quarters, going back to Q3 2026.
What is Yorkville Advisors Global, LP's current position in VRXA?
As of Q3 2026, Yorkville Advisors Global, LP holds 1.04M shares of VRXA (Veraxa Biotech AG), valued at $1.30M, representing 1.18% of its reported portfolio and ranking #15.
Has Yorkville Advisors Global, LP been buying or selling VRXA?
In the latest 13F filing (Q3 2026), Yorkville Advisors Global, LP newly opened its position in VRXA.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.